Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)
China · Delayed Price · Currency is CNY 12.90
+0.28 (2.22%)
May 29, 2026, 3:04 PM CST
SHE:000403 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 353.15 | 419.27 | 745.32 | 612.11 | 587.13 | 391.06 |
Depreciation & Amortization | 137.34 | 137.34 | 131.44 | 145.47 | 126.39 | 115.76 |
Other Amortization | 14.06 | 14.06 | 4.45 | 0.65 | 4.43 | 7.39 |
Loss (Gain) From Sale of Assets | -0.76 | -0.76 | 0.12 | 0.54 | -0.44 | -0.27 |
Asset Writedown & Restructuring Costs | 96.46 | 96.46 | 3.46 | 1.29 | 3.59 | 103.67 |
Loss (Gain) From Sale of Investments | -13.25 | -13.25 | -24.12 | -17.56 | -7.97 | -77.91 |
Provision & Write-off of Bad Debts | 8.78 | 8.78 | -4.6 | -2.04 | 9.66 | 9.44 |
Other Operating Activities | -17.51 | -27.62 | -39.45 | -14.95 | -38.62 | -33.92 |
Change in Accounts Receivable | -472.67 | -472.67 | -131.42 | 274.65 | -329.07 | -196.58 |
Change in Inventory | -332.41 | -332.41 | -325.13 | -285.42 | 115.51 | 1.72 |
Change in Accounts Payable | -47.79 | -47.79 | -47.76 | -31.26 | 70.94 | 70.06 |
Change in Other Net Operating Assets | - | - | - | 2.23 | 10.6 | 21.65 |
Operating Cash Flow | -272 | -215.99 | 321.79 | 679.01 | 524.22 | 408.22 |
Operating Cash Flow Growth | - | - | -52.61% | 29.53% | 28.42% | 109.52% |
Capital Expenditures | -272.83 | -333.4 | -520.71 | -377.27 | -378.64 | -326.16 |
Sale of Property, Plant & Equipment | 0.44 | 0.49 | 0.11 | 1.65 | 0.45 | 1.35 |
Cash Acquisitions | - | - | - | - | - | 64.57 |
Investment in Securities | 490 | 30 | 124.3 | 9.25 | -259.36 | -160 |
Other Investing Activities | -29.94 | 71.59 | 60.36 | 77.15 | 81.18 | -258.03 |
Investing Cash Flow | 187.66 | -231.32 | -335.94 | -289.21 | -556.38 | -678.28 |
Long-Term Debt Issued | - | 771.21 | 571.81 | 438.32 | 481.79 | 303.16 |
Total Debt Issued | 754.41 | 771.21 | 571.81 | 438.32 | 481.79 | 303.16 |
Long-Term Debt Repaid | - | -601.01 | -415.1 | -316.89 | -263.4 | -833.63 |
Total Debt Repaid | -627 | -601.01 | -415.1 | -316.89 | -263.4 | -833.63 |
Net Debt Issued (Repaid) | 127.41 | 170.19 | 156.72 | 121.43 | 218.39 | -530.47 |
Issuance of Common Stock | - | - | 14.22 | 8.3 | 2.51 | 1,597 |
Repurchase of Common Stock | - | - | - | -24.23 | -21.98 | - |
Common Dividends Paid | -274.47 | -273.8 | -264.63 | -66.79 | -49.66 | -12.05 |
Other Financing Activities | 0.43 | 0.1 | -0.06 | -0.47 | -0.8 | 1.76 |
Financing Cash Flow | -146.63 | -103.51 | -93.74 | 38.24 | 148.46 | 1,056 |
Foreign Exchange Rate Adjustments | 0.02 | 0.05 | -0.03 | -0.02 | -1.19 | -0.23 |
Net Cash Flow | -230.95 | -550.76 | -107.92 | 428.01 | 115.11 | 785.52 |
Free Cash Flow | -544.84 | -549.39 | -198.92 | 301.74 | 145.58 | 82.06 |
Free Cash Flow Growth | - | - | - | 107.27% | 77.41% | -46.94% |
Free Cash Flow Margin | -20.95% | -20.87% | -7.49% | 12.96% | 6.05% | 4.16% |
Free Cash Flow Per Share | -0.55 | -0.58 | -0.21 | 0.32 | 0.15 | 0.09 |
Cash Income Tax Paid | 242.87 | 217.87 | 252.75 | 213.87 | 172 | 148.92 |
Levered Free Cash Flow | -672.01 | -656.41 | -316.89 | 186.27 | -7.27 | -289.45 |
Unlevered Free Cash Flow | -659.76 | -645.04 | -310.22 | 192.28 | 0.25 | -282.71 |
Change in Working Capital | -850.27 | -850.27 | -494.83 | -46.5 | -159.95 | -107 |